OUTSET MEDICAL INC (OM) Stock Analyst Earnings Estimates
NASDAQ:OM - Nasdaq - US6901452069 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 115.4M 12.48% | 130.376M 12.98% | 113.689M -12.80% | 125.68M 10.55% | 140.6M 11.87% | 156.94M 11.62% | 192.92M 22.93% | 216.2M 12.07% | 239.06M 10.57% | |
| EBITDA YoY % growth | -155.83M -24.33% | -163.96M -5.22% | -102.671M 37.38% | -39.895M 61.14% | -40.548M -1.64% | -31.93M 21.25% | -1.648M 94.84% | 9.579M 681.25% | 21.527M 124.73% | |
| EBIT YoY % growth | -161M -23.37% | -169.77M -5.45% | -108.399M 36.15% | -50.946M 53.00% | -47.403M 6.95% | -34.471M 27.28% | -3.914M 88.65% | 7.519M 292.11% | 19.261M 156.16% | |
| Operating Margin | -139.51% | -130.22% | -95.35% | -40.54% | -33.71% | -21.96% | -2.03% | 3.48% | 8.06% | |
| EPS YoY % growth | -51.15 -18.40% | -46.50 9.09% | -27.00 41.94% | -5.33 80.28% | -3.95 25.82% | -3.79 4.04% | -0.63 83.42% | 0.03 104.92% | 0.87 2,700.00% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.91 84.42% | -0.78 85.90% | -0.72 77.75% | -0.64 23.36% | -0.55 39.55% | -0.45 42.76% |
| Revenue Q2Q % growth | 31.436M 9.66% | 33.681M 14.30% | 31.364M 5.42% | 33.681M 7.20% | 36.153M 15.01% | 38.934M 15.60% |
| EBITDA Q2Q % growth | -9.27M 52.50% | -7.656M 52.54% | -10.815M 28.40% | -9.528M 8.42% | -7.88M 15.00% | -6.077M 20.63% |
| EBIT Q2Q % growth | -12.22M 48.74% | -8.781M 59.83% | -11.742M 28.40% | -10.3M 22.80% | -8.601M 29.62% | -6.695M 23.75% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.84 88.09% | -1.01 | 0.17 | 16.99% |
| Q1 2025 Q2Q % growth | -3.24 62.11% | -0.97 | -2.27 | -232.87% |
| Q4 2024 Q2Q % growth | -5.55 37.29% | -6.37 | 0.82 | 12.92% |
| Q3 2024 Q2Q % growth | -5.85 45.07% | -6.51 | 0.66 | 10.20% |
| Q2 2024 Q2Q % growth | -7.05 47.78% | -6.98 | -0.07 | -1.03% |
| Q1 2024 Q2Q % growth | -8.55 36.67% | -8.48 | -0.07 | -0.88% |
| Q4 2023 Q2Q % growth | -8.85 31.40% | -9.50 | 0.65 | 6.86% |
| Q3 2023 Q2Q % growth | -10.65 16.47% | -10.30 | -0.35 | -3.40% |
| Q2 2023 Q2Q % growth | -13.50 2.17% | -11.78 | -1.72 | -14.59% |
| Q1 2023 Q2Q % growth | -13.50 -15.38% | -11.46 | -2.04 | -17.76% |
| Q4 2022 Q2Q % growth | -12.90 1.15% | -13.29 | 0.39 | 2.91% |
| Q3 2022 Q2Q % growth | -12.75 -30.77% | -12.51 | -0.24 | -1.88% |
| Q2 2022 Q2Q % growth | -13.80 -39.39% | -10.78 | -3.02 | -27.97% |
| Q1 2022 Q2Q % growth | -11.70 -11.43% | -11.12 | -0.58 | -5.18% |
| Q4 2021 Q2Q % growth | -13.05 -16.00% | -11.86 | -1.19 | -10.05% |
| Q3 2021 Q2Q % growth | -9.75 80.36% | -11.28 | 1.53 | 13.55% |
| Q2 2021 Q2Q % growth | -9.90 | -10.78 | 0.88 | 8.20% |
| Q1 2021 Q2Q % growth | -10.50 | -12.54 | 2.04 | 16.25% |
| Q4 2020 Q2Q % growth | -11.25 | -10.26 | -0.99 | -9.66% |
| Q3 2020 Q2Q % growth | -49.65 | -47.95 | -1.70 | -3.55% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 31.42M 14.72% | 30.29M | 1.13M | 3.73% |
| Q1 2025 Q2Q % growth | 29.752M 5.62% | 28.646M | 1.106M | 3.86% |
| Q4 2024 Q2Q % growth | 29.467M -3.41% | 29.328M | 139K | 0.47% |
| Q3 2024 Q2Q % growth | 28.666M -5.59% | 27.712M | 954K | 3.44% |
| Q2 2024 Q2Q % growth | 27.388M -24.01% | 32.123M | -4.735M | -14.74% |
| Q1 2024 Q2Q % growth | 28.168M -15.83% | 31.251M | -3.083M | -9.87% |
| Q4 2023 Q2Q % growth | 30.507M -4.70% | 31.316M | -809K | -2.58% |
| Q3 2023 Q2Q % growth | 30.362M 9.37% | 31.302M | -940K | -3.00% |
| Q2 2023 Q2Q % growth | 36.04M 43.81% | 35.838M | 202K | 0.56% |
| Q1 2023 Q2Q % growth | 33.467M 9.55% | 32.712M | 755K | 2.31% |
| Q4 2022 Q2Q % growth | 32.01M 13.71% | 31.85M | 160K | 0.50% |
| Q3 2022 Q2Q % growth | 27.76M 5.47% | 25.979M | 1.781M | 6.86% |
| Q2 2022 Q2Q % growth | 25.06M -0.63% | 28.316M | -3.256M | -11.50% |
| Q1 2022 Q2Q % growth | 30.55M 33.29% | 31.013M | -463K | -1.49% |
| Q4 2021 Q2Q % growth | 28.15M 63.19% | 27.218M | 932K | 3.42% |
| Q3 2021 Q2Q % growth | 26.32M 91.28% | 25.876M | 444K | 1.72% |
| Q2 2021 Q2Q % growth | 25.22M 114.82% | 24.448M | 772K | 3.16% |
| Q1 2021 Q2Q % growth | 22.92M 218.78% | 22.096M | 824K | 3.73% |
| Q4 2020 Q2Q % growth | 17.25M | 14.167M | 3.083M | 21.76% |
| Q3 2020 Q2Q % growth | 13.76M | 11.908M | 1.852M | 15.55% |
| Q2 2020 Q2Q % growth | 11.74M 309.06% | % | ||
| Q1 2020 Q2Q % growth | 7.19M 188.76% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -23.85% | 0% | -55.84% |
| Revenue | 0.37% | 0.93% | -0.23% | 1.44% |